13F-HR filed by Trails Edge Capital Partners, LP
Trails Edge Capital Partners, LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 35 holding rows worth $629,911,888.
- Accession
- 0002077247-26-000004
- Filer
- CIK 2077247
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 35 entries on the cover page, a total value of $629,911,888 stated on the cover page (in dollars after the unit check, H1), rows summing to $629,911,888 with VALUE read as dollars as filed, 13F file number 028-26566. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 1,523,022 | $49,429,679 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,573,220 | $38,166,318 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 1,063,234 | $33,757,680 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 1,514,000 | $30,461,680 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 2,227,917 | $29,631,296 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 512,000 | $29,296,640 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,001,282 | $28,958,550 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 440,000 | $26,558,400 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 223,312 | $26,143,136 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 230,331 | $24,557,891 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 288,089 | $24,542,302 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,110,000 | $24,264,600 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 714,885 | $22,483,133 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 984,786 | $21,694,836 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 115,750 | $21,677,660 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 9,051,318 | $18,374,176 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 155,000 | $17,570,800 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 891,881 | $16,481,961 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 750,000 | $14,602,500 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 515,335 | $12,883,375 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 2,571,478 | $12,008,803 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 2,743,658 | $11,276,434 | dollars as filed | |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 139,445 | $10,338,452 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 1,443,333 | $10,247,665 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 4,134,969 | $10,130,674 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 2,657,997 | $10,047,228 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 1,932,937 | $8,446,935 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 2,660,000 | $8,086,400 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,419,000 | $7,875,450 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 557,103 | $7,331,475 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,438,456 | $6,559,359 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G208 | COMMON STOCK | 273,181 | $5,805,097 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 500,000 | $5,350,000 | dollars as filed | |
| VTV THERAPEUTICS INC | 918385204 | CL A NEW | 85,192 | $3,207,479 | dollars as filed | |
| IMAGENEBIO INC | 45175G207 | CMN | 282,004 | $1,663,824 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002077247-26-000004 | this filing | 2026-08-14 | acceptance time not in the bulk data set |